Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Quetiapine; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2008 Planned end date changed from 1 Apr 2009 to 1 Sep 2008 as reported by ClinicalTrials.gov.
- 03 Nov 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.